Skip to main content
Livermore
Livermore
ZHEN

Aspiriant, LLC

SEC CIK
0001433541
Latest filing
Jul 20, 2026

BMY holding history

Bristol Myers Squibb Co in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMY overviewAll 13F holders of BMYFull Q2 2026 holdings

Shares (Q2 2026)
18,578
Value
$1.07M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMY by Aspiriant, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,578$1.07M<0.1%+8,191+78.9%AddedHolders
Q1 202610,387$630.0K<0.1%+835+8.7%AddedHolders
Q4 20259,552$515.2K<0.1%+3,349+54.0%AddedHolders
Q3 20256,203$279.7K<0.1%−1,450−18.9%ReducedHolders
Q2 20257,653$354.2K<0.1%−76−1.0%ReducedHolders
Q1 20257,729$471.4K<0.1%+157+2.1%AddedHolders
Q4 20247,572$428.3K<0.1%−520−6.4%ReducedHolders
Q3 20248,092$418.7K<0.1%+1,303+19.2%AddedHolders
Q2 20246,789$282.0K<0.1%−2,329−25.5%ReducedHolders
Q1 20249,118$494.5K<0.1%+702+8.3%AddedHolders
Q4 20238,416$431.9K<0.1%+849+11.2%AddedHolders
Q3 20237,567$439.2K<0.1%−6,054−44.4%ReducedHolders
Q2 202313,621$871.0K<0.1%−736−5.1%ReducedHolders
Q1 202314,357$995.1K0.1%−50−0.3%ReducedHolders
Q4 202214,407$1.04M0.1%+1,388+10.7%AddedHolders
Q3 202213,019$925.0K<0.1%+111+0.9%AddedHolders
Q2 202212,908$995.0K<0.1%+2,707+26.5%AddedHolders
Q1 202210,201$745.0K<0.1%−1,881−15.6%ReducedHolders
Q4 202112,082$753.0K<0.1%+4,424+57.8%AddedHolders
Q3 20217,658$453.0K<0.1%−125−1.6%ReducedHolders
Q2 20217,783$519.0K<0.1%+69+0.9%AddedHolders
Q1 20217,714$487.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.